As of 2024-10-05, the Relative Valuation of MEI Pharma Inc (MEIP) is 78.91 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.81 USD, the upside of MEI Pharma Inc based on Relative Valuation is 2708.2%.
The range of the Relative Valuation is 46.54 - 130.98 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.6x - 49.1x | 40.4x |
| Forward P/E multiples | 22.9x - 26.4x | 24.6x |
| Fair Price | 46.54 - 130.98 | 78.91 |
| Upside | 1556.1% - 4561.3% | 2708.2% |
| Date | P/E |
| 2024-10-04 | 1.05 |
| 2024-10-03 | 1.03 |
| 2024-10-02 | 1.03 |
| 2024-10-01 | 1.05 |
| 2024-09-30 | 1.07 |
| 2024-09-27 | 1.09 |
| 2024-09-26 | 1.09 |
| 2024-09-25 | 1.07 |
| 2024-09-24 | 1.11 |
| 2024-09-23 | 1.10 |
| 2024-09-20 | 1.12 |
| 2024-09-19 | 1.18 |
| 2024-09-18 | 1.14 |
| 2024-09-17 | 1.12 |
| 2024-09-16 | 1.14 |
| 2024-09-13 | 1.14 |
| 2024-09-12 | 1.15 |
| 2024-09-11 | 1.13 |
| 2024-09-10 | 1.16 |
| 2024-09-09 | 1.11 |
| 2024-09-06 | 1.16 |
| 2024-09-05 | 1.18 |
| 2024-09-04 | 1.16 |
| 2024-09-03 | 1.17 |
| 2024-08-30 | 1.16 |
| 2024-08-29 | 1.22 |
| 2024-08-28 | 1.17 |
| 2024-08-27 | 1.19 |
| 2024-08-26 | 1.19 |
| 2024-08-23 | 1.18 |
| 2024-08-22 | 1.14 |
| 2024-08-21 | 1.18 |
| 2024-08-20 | 1.17 |
| 2024-08-19 | 1.16 |
| 2024-08-16 | 1.19 |
| 2024-08-15 | 1.19 |
| 2024-08-14 | 1.27 |
| 2024-08-13 | 1.27 |
| 2024-08-12 | 1.29 |
| 2024-08-09 | 1.27 |
| 2024-08-08 | 1.27 |
| 2024-08-07 | 1.29 |
| 2024-08-06 | 1.26 |
| 2024-08-05 | 1.30 |
| 2024-08-02 | 1.27 |
| 2024-08-01 | 1.30 |
| 2024-07-31 | 1.39 |
| 2024-07-30 | 1.28 |
| 2024-07-29 | 1.32 |
| 2024-07-26 | 1.33 |